Director/PDMR Shareholding
On September 26, 2025, Mark Nurse, husband of Katrina Nurse, a Non-Executive Director, sold 10,000 ordinary shares in Thruvision Group PLC at a price of 1.23 pence per share. Following this transaction, Katrina Nurse and her closely associated persons' beneficial shareholding is 258,000 ordinary shares, representing 0.06% of the company's total issued share capital and total voting rights. The ordinary shares are valued at £0.01 each with identification code GB00B627R876 and the transaction took place on the London Stock Exchange.
Select text to share a quote on X · sign in to keep highlights & notes in your THRU notes
Thruvision (AIM: THRU, "Thruvision" or the "Group"), the leading international provider of walk- through security technology, announces that on 26 September 2025 Mark Nurse, the husband and accordingly a person closely associated ("PCA") with Katrina Nurse, sold 10,000 ordinary shares in the Company at a price of 1.23 pence.
Following this transaction, the beneficial shareholding in the Company of Katrina Nurse and her PCAs is 258,000 ordinary shares, representing 0.06% of the Company's total issued share capital and total voting rights.
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| (a) | Name | Mark Nurse, husband of Katrina Nurse | |
| 2. | Reason for the notification | ||
| (a) | Position/status | Person closely associated with Katrina Nurse, a Non-Executive Director | |
| (b) | Initial notification/ Amendment | Initial notification | |
| 3. | Details of the issuer | ||
| (a) | Name | Thruvision Group plc | |
| (b) | LEI | 213800IZG9GM6G2TZE04 | |
| (a) | Description of the Financial Instrument | Ordinary shares of £0.01 each | |
| (b) | Identification code of the Financial Instrument | GB00B627R876 | |
| (c) | Nature of the transaction | Sale of shares | |
| (d) | Price(s) and volume(s) | Price(s) | Volume(s) |
| 1.23 pence | 10,000 | ||
| (e) | Aggregated information - Aggregated volume - Price | N/A | |
| (f) | Date of the transaction | 26 September 2025 | |
| (g) | Place of the transaction | London Stock Exchange |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.